ArticleLeukemia2017

Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma.

K T Siu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.